Frailty assessment in patients with advanced/metastatic renal cell carcinoma using routine data collected during treatment with tyrosine kinase inhibitors in the STAR trial. ML analysis results: ...
Correspondence to Dr Rachel Chester, School of Health Sciences, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7TJ, UK; r.chester{at}uea.ac.uk Objectives To (i) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback